NICE guidance on new heart failure drug

27 April 2016        

Developing mouse heart shown in red and blue

Health authority NICE has recommended a new drug that could help transform the lives of people living in heart failure.  

Sacubitril valsartan is the first drug of its kind and looks to manage the symptoms for people with heart failure.  

In addition, it has the potential to reduce the more than 30,000 hospital admissions and prevent deaths.

The drug will only be suitable to around 100,000 people whose heart is only able to pump a reduced amount of oxygenated blood around the body not already controlled by medicine.

Professor Peter Weissberg our Medical Director said:

"There is currently no cure for heart failure and we welcome the news that this drug will now be available to some patients to help control and manage their condition.

"In the UK, over half a million people are living with this crippling illness which can cause chronic breathlessness and fatigue, leaving patients with a long and difficult fight for life.

"Through generous donations to our Mending Broken Hearts Appeal, we have been able to fund around £25million of regenerative medicine research. Recent advances in this field have shown that repairing the heart after a heart attack, something that is currently impossible, is a realistic goal.

"But we must fund more research to develop promising discoveries made in the lab into treatments for people living with debilitating heart failure."

Help mend broken hearts